Literature DB >> 35776259

ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.

Junya Toyoda1, Kota Sahara1,2, Itaru Endo1, Timothy M Pawlik3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35776259     DOI： 10.1245/s10434-022-12105-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  4 in total

1.  ASO Author Reflections: Development and Validation of Distal Cholangiocarcinoma Early Recurrence (DICER) Score: Results from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Kota Sahara; Diamantis I Tsilimigras; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2021-03-21       Impact factor: 5.344

2.  Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?

Authors:  Diamantis I Tsilimigras; J Madison Hyer; Anghela Z Paredes; Dimitrios Moris; Kota Sahara; Alfredo Guglielmi; Luca Aldrighetti; Matthew Weiss; Todd W Bauer; Sorin Alexandrescu; George A Poultsides; Shishir K Maithel; Hugo P Marques; Guillaume Martel; Carlo Pulitano; Feng Shen; Olivier Soubrane; Bas Groot Koerkamp; Itaru Endo; Kazunari Sasaki; Federico Aucejo; Xu-Feng Zhang; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2020-12-01       Impact factor: 5.344

3.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.